Timothy C Durazzo1, Dieter J Meyerhoff, Sara Jo Nixon. 1. Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco VA Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA. timothy.durazzo@ucsf.edu
Abstract
BACKGROUND: The majority of studies investigating the neurocognitive consequences of chronic smoking have been conducted with adults 60 years and older. Therefore, the scope of neurocognitive dysfunction associated with chronic cigarette smoking in middle age (i.e., 30-60 age range) has not been fully delineated. METHODS: Twenty-seven (44±9 years of age; 4 females) non-smoking and 30 smoking (49±8 years of age; 4 females) participants completed a comprehensive neurocognitive battery and measures of fine motor dexterity and postural stability. All participants were free of biomedical or psychiatric conditions that may have influenced neurocognitive and motor function. RESULTS: Smokers performed significantly worse than non-smokers on the following domains: auditory-verbal and visuospatial learning, visuospatial memory, cognitive efficiency, executive skills, general intelligence, processing speed, fine motor dexterity and postural stability. The differences between smokers and non-smokers evidenced moderate to strong effect sizes and were not mediated by age, education, vocational level, estimated verbal intelligence or alcohol consumption. In smokers, a greater number of lifetime years of smoking was related to poorer performance on measures of cognitive efficiency, processing speed and visuospatial skills. CONCLUSIONS: Results from this middle-aged cohort replicated previous research and provides novel findings indicating that chronic smoking was associated with inferior performance on measures of general intelligence, visuospatial learning and memory and fine motor dexterity. Research that relates measures of neurobiological function/integrity to neurocognition is needed to better understand the mechanisms contributing to the poorer performance across multiple domains demonstrated by smokers. Published by Elsevier Ireland Ltd.
BACKGROUND: The majority of studies investigating the neurocognitive consequences of chronic smoking have been conducted with adults 60 years and older. Therefore, the scope of neurocognitive dysfunction associated with chronic cigarette smoking in middle age (i.e., 30-60 age range) has not been fully delineated. METHODS: Twenty-seven (44±9 years of age; 4 females) non-smoking and 30 smoking (49±8 years of age; 4 females) participants completed a comprehensive neurocognitive battery and measures of fine motor dexterity and postural stability. All participants were free of biomedical or psychiatric conditions that may have influenced neurocognitive and motor function. RESULTS: Smokers performed significantly worse than non-smokers on the following domains: auditory-verbal and visuospatial learning, visuospatial memory, cognitive efficiency, executive skills, general intelligence, processing speed, fine motor dexterity and postural stability. The differences between smokers and non-smokers evidenced moderate to strong effect sizes and were not mediated by age, education, vocational level, estimated verbal intelligence or alcohol consumption. In smokers, a greater number of lifetime years of smoking was related to poorer performance on measures of cognitive efficiency, processing speed and visuospatial skills. CONCLUSIONS: Results from this middle-aged cohort replicated previous research and provides novel findings indicating that chronic smoking was associated with inferior performance on measures of general intelligence, visuospatial learning and memory and fine motor dexterity. Research that relates measures of neurobiological function/integrity to neurocognition is needed to better understand the mechanisms contributing to the poorer performance across multiple domains demonstrated by smokers. Published by Elsevier Ireland Ltd.
Authors: Robert H Paul; Adam M Brickman; Ronald A Cohen; Leanne M Williams; Raymond Niaura; Sakire Pogun; C Richard Clark; John Gunstad; Evian Gordon Journal: J Clin Neurosci Date: 2006-05 Impact factor: 1.961
Authors: Timothy C Durazzo; Susanna L Fryer; Johannes C Rothlind; Mary Vertinski; Stefan Gazdzinski; Anderson Mon; Dieter J Meyerhoff Journal: Alcohol Alcohol Date: 2010-10-05 Impact factor: 2.826
Authors: Ben Lewis; Christian C Garcia; Jeff Boissoneault; Julianne L Price; Sara Jo Nixon Journal: J Stud Alcohol Drugs Date: 2019-01 Impact factor: 2.582
Authors: Andrea H Weinberger; Lauren R Pacek; Daniel Giovenco; Sandro Galea; Michael J Zvolensky; Misato Gbedemah; Renee D Goodwin Journal: Alcohol Clin Exp Res Date: 2018-12-10 Impact factor: 3.455
Authors: Anderson Mon; Timothy C Durazzo; Christoph Abe; Stefan Gazdzinski; David Pennington; Thomas Schmidt; Dieter J Meyerhoff Journal: Drug Alcohol Depend Date: 2014-09-19 Impact factor: 4.492
Authors: David L Pennington; Timothy C Durazzo; Thomas P Schmidt; Anderson Mon; Christoph Abé; Dieter J Meyerhoff Journal: Alcohol Clin Exp Res Date: 2013-02-21 Impact factor: 3.455
Authors: Joseph D Harrison; Jessica A Dochney; Sonja Blazekovic; Frank Leone; David Metzger; Ian Frank; Robert Gross; Anita Hole; Karam Mounzer; Steven Siegel; Robert A Schnoll; Rebecca L Ashare Journal: J Neurovirol Date: 2017-04-20 Impact factor: 2.643
Authors: Timothy C Durazzo; Linda Abadjian; Adam Kincaid; Tobias Bilovsky-Muniz; Lauren Boreta; Grant E Gauger Journal: J Neurotrauma Date: 2013-06-06 Impact factor: 5.269